ATE258386T1 - Schmackhaftes elementares medizinisches nahrungsmittel - Google Patents

Schmackhaftes elementares medizinisches nahrungsmittel

Info

Publication number
ATE258386T1
ATE258386T1 AT98928961T AT98928961T ATE258386T1 AT E258386 T1 ATE258386 T1 AT E258386T1 AT 98928961 T AT98928961 T AT 98928961T AT 98928961 T AT98928961 T AT 98928961T AT E258386 T1 ATE258386 T1 AT E258386T1
Authority
AT
Austria
Prior art keywords
formula
nutritional
source
calories
nutritionally complete
Prior art date
Application number
AT98928961T
Other languages
German (de)
English (en)
Inventor
Phyllis J B Agosta
Marlene W Borschel
Patricia A Reynolds
Christopher T Cordle
Geralyn O Duska-Mceven
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE258386T1 publication Critical patent/ATE258386T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
AT98928961T 1997-07-02 1998-06-10 Schmackhaftes elementares medizinisches nahrungsmittel ATE258386T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/887,001 US5922766A (en) 1997-07-02 1997-07-02 Palatable elemental medical food
PCT/US1998/011986 WO1999001044A1 (en) 1997-07-02 1998-06-10 Palatable elemental medical food

Publications (1)

Publication Number Publication Date
ATE258386T1 true ATE258386T1 (de) 2004-02-15

Family

ID=25390249

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928961T ATE258386T1 (de) 1997-07-02 1998-06-10 Schmackhaftes elementares medizinisches nahrungsmittel

Country Status (11)

Country Link
US (2) US5922766A (enExample)
EP (1) EP0994657B1 (enExample)
JP (1) JP4467650B2 (enExample)
AT (1) ATE258386T1 (enExample)
CA (1) CA2294086C (enExample)
DE (1) DE69821359T2 (enExample)
DK (1) DK0994657T3 (enExample)
ES (1) ES2215304T3 (enExample)
NO (1) NO316732B1 (enExample)
PT (1) PT994657E (enExample)
WO (1) WO1999001044A1 (enExample)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US5981590A (en) * 1997-03-17 1999-11-09 Probiotix, Inc. Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
JP3362350B2 (ja) * 1997-10-16 2003-01-07 味の素株式会社 反芻動物の肥育方法
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6203820B1 (en) * 1998-05-28 2001-03-20 Brice E. Vickery Compositions and methods for enhancing protein anabolism and detoxification
FR2784601B1 (fr) * 1998-09-21 2000-11-17 Gerard Auberger Concentre hydrosoluble obtenu a partir d'une phase emulgatrice ou hydrosolubilisante et d'un complexe de matieres lipophiles liquides d'origine vegetale
ATE228779T1 (de) * 1999-01-20 2002-12-15 Nutricia Nv Säuglingsnährpräparat
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
US6214351B1 (en) * 1999-08-27 2001-04-10 Morinda, Inc. Morinda citrifolia oil
WO2001026665A1 (en) * 1999-10-15 2001-04-19 Bawa Rajan S Liquid nutritional supplement composition and method of preparation
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
AU2001227889A1 (en) * 2000-01-14 2001-07-24 The United States of America, represented by The Secretary, Department of Health & Human Services Oligodeoxynucleotide and its use to induce an immune response
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
HUP0204439A3 (en) * 2000-02-04 2004-12-28 Nestle Sa A method for maintaining or improving the synthesis of mucins
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
UA77660C2 (en) * 2000-10-03 2007-01-15 Compositions and methods for reducing plasma lipoprotein a level in human
ATE320831T1 (de) * 2000-10-06 2006-04-15 Dmg Italia Srl Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement
DE10057290B4 (de) 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US7048952B2 (en) * 2002-05-21 2006-05-23 Morinda, Inc. Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US20070196527A1 (en) * 2006-02-23 2007-08-23 Jensen Claude J Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
DE20101225U1 (de) * 2001-01-24 2001-06-13 Sportmedizin Team Vertriebs Gmbh, Berneck Präparat für hohe körperliche Beanspruchung
WO2002069964A1 (en) 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
MXPA03007802A (es) * 2001-03-09 2003-12-08 Nestle Sa Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad.
JP2005511479A (ja) * 2001-04-17 2005-04-28 モリンダ・インコーポレーテッド モリンダシトリフォリア油および果汁の緩和作用
FR2825003B1 (fr) † 2001-05-28 2005-01-28 Taan Aboudiab Dispositif pour un aliment dietetique de substitution au lait et au soja
AUPR626201A0 (en) * 2001-07-10 2001-08-02 Bioscreen Pty Ltd A composition for use in prophylaxis and/or treatment
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
US7354909B2 (en) 2001-08-14 2008-04-08 The United States Of America As Represented By Secretary Of The Department Of Health And Human Services Method for rapid generation of mature dendritic cells
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US20030109582A1 (en) * 2001-12-10 2003-06-12 Zasloff Michael A. Methods and compositions for stimulating secretions from paneth cells
US7615227B2 (en) 2001-12-20 2009-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce angiogenesis
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
AU2002367129A1 (en) * 2001-12-25 2003-07-15 Ajinomoto Co., Inc. Organ fibrosis inhibitors
US8263091B2 (en) * 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
GB2396809A (en) * 2003-01-03 2004-07-07 Vitabiotics Ltd Composition for the treatment of HIV and AIDS
EP1594364A1 (en) * 2003-02-14 2005-11-16 Mars Uk Limited Skin composition
RU2221456C1 (ru) * 2003-03-11 2004-01-20 Общество с ограниченной ответственностью "Арсентех" Биологически активное вещество, биологически активная добавка к пище, фармацевтический препарат, биологически активная добавка для кормления животных, ветеринарный препарат, удобрение, активатор микробиологических процессов, пероральное питание, парфюмерно-косметическое средство, гигиеническое средство, молочный продукт, кондитерское изделие, хлебобулочное изделие, масло-жировой продукт, соус, алкогольный напиток, безалкогольный напиток, рыбный продукт, мясной продукт, макаронные изделия, жевательная резинка, пиво
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
WO2005110123A1 (en) * 2003-04-25 2005-11-24 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US20050106275A1 (en) * 2003-05-02 2005-05-19 Chen Su Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7824706B2 (en) 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US7658964B2 (en) 2003-05-09 2010-02-09 Freedom Health, Llc Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
ES2282880T3 (es) * 2003-05-22 2007-10-16 N.V. Nutricia Metodo para tratar o prevenir heridas cronicas y composicion nutritiv a completa comprendiendo glicina y/o leucina para usar en este.
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
UA83063C2 (ru) * 2003-08-19 2008-06-10 Фарматон С.А. Сироп для детей иЛИ подростков, содержащий поливитамИНЫ
AU2004269874B2 (en) * 2003-09-10 2007-09-20 Unilever Plc Food composition
JP4147280B2 (ja) * 2003-12-16 2008-09-10 独立行政法人理化学研究所 グルタミン含有エネルギー付加型アミノ酸組成物又はアミノ酸溶液
ES2314485T3 (es) * 2003-12-24 2009-03-16 N.V. Nutricia Composiciones que comprenden acido pantotenico o derivados del mismo y su uso para estimular el apetito.
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
EP2705849B1 (en) 2004-07-19 2018-04-04 N.V. Nutricia A preparation for use of aspartate for regulating glucose levels in blood
WO2006028826A2 (en) * 2004-09-01 2006-03-16 Paulus Wang Morinda citrifolia-based formulations and methods for weight management
US20060141076A1 (en) * 2004-11-01 2006-06-29 Palu Afa K Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US7982066B2 (en) * 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
US20070237848A1 (en) * 2005-12-21 2007-10-11 Brad Rawson MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
US20070202058A1 (en) * 2006-02-27 2007-08-30 Calwood Nutritionals, Inc. Compositions for treating gastric reflux
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
WO2008010472A1 (en) * 2006-07-18 2008-01-24 Ajinomoto Co., Inc. Total enteral nutrition composition
US8722120B2 (en) * 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations
WO2008014733A1 (de) * 2006-08-02 2008-02-07 Johannes Gutenberg-Universität Mainz Arzneimittel gegen lct-vergiftungen
MX2010000172A (es) * 2006-08-04 2012-09-25 Shs Int Ltd Formula libre de proteina.
US20080226758A1 (en) * 2006-11-28 2008-09-18 Shixin Deng Lipoxygenase and Cyclooxygenase Inhibition
US20080213415A1 (en) * 2007-02-08 2008-09-04 Palu Afa K Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
JP5527986B2 (ja) * 2008-02-19 2014-06-25 株式会社アーネストメディスン 医薬組成物
EP2255818B1 (en) * 2008-02-19 2018-08-22 Earnest Medicine Co., Ltd. Oral or enteral composition useful for recovery of physical functions
US7819382B2 (en) * 2008-05-09 2010-10-26 Gm Global Technology Operations, Inc. Temperature and pressure responsive seal
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
JP2011121888A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121887A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121889A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011144116A (ja) * 2010-01-12 2011-07-28 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用添加剤
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
WO2014062683A1 (en) * 2012-10-15 2014-04-24 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
FI2988617T3 (fi) * 2013-03-27 2023-11-22 Nutritional Growth Solutions Ltd Ravintolisä kasvun tehostamiseksi
WO2015034984A1 (en) 2013-09-05 2015-03-12 Emory University Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
US10124036B2 (en) 2015-06-12 2018-11-13 Cambrooke Therapeutics, Inc. Liquid nutritional formula for tyrosinemia patients
ES2914650T3 (es) 2016-04-27 2022-06-15 Abergavenny Nv Sal de butirato de colina
FR3059522B1 (fr) * 2016-12-02 2019-01-25 Ajinomoto Co., Inc. Aliment et son utilisation pour la prophylaxie ou l'amelioration de la malnutrition
CN112823018A (zh) * 2018-06-20 2021-05-18 胺细拉健康公司 制备氨基酸组合物的方法
EP3873236B1 (en) 2018-11-02 2025-02-26 Société des Produits Nestlé S.A. Powders containing a buffer salt and an amino acid, reconstitution of such a powder into a nutritional product, and methods of using such a nutritional product
JP7458620B2 (ja) * 2019-06-21 2024-04-01 株式会社大塚製薬工場 栄養組成物
PL4190173T3 (pl) 2020-09-23 2025-01-07 Aminovita S.L. Metaboliczna terapia przeciwnowotworowa
WO2025085933A1 (en) * 2023-10-20 2025-04-24 Good Lfe Llc Compositions and methods for treating gastrointestinal-related diseases and disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
US5039704A (en) * 1985-09-12 1991-08-13 Brigham And Women's Hospital Method of treating catabolic dysfunction
US5411757A (en) * 1989-11-09 1995-05-02 Buist; Neil R. M. Palatable balanced amino acid-modified diet
CA2097196C (en) * 1991-10-07 1999-04-13 Shozo Aoi Enteral preparation for cancer therapy
US5234702A (en) * 1992-03-19 1993-08-10 Abbott Laboratories Antioxidant system for powdered nutritional products
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
WO1994014458A1 (en) * 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
US5340603A (en) * 1993-08-30 1994-08-23 Abbott Laboratories Nutritional product for human infants having chronic lung disease
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition

Also Published As

Publication number Publication date
CA2294086C (en) 2009-09-15
US6245803B1 (en) 2001-06-12
NO20000010D0 (no) 2000-01-03
JP4467650B2 (ja) 2010-05-26
WO1999001044A1 (en) 1999-01-14
DK0994657T3 (da) 2004-06-07
NO316732B1 (no) 2004-04-19
CA2294086A1 (en) 1999-01-14
DE69821359D1 (de) 2004-03-04
DE69821359T2 (de) 2004-12-09
JP2002510317A (ja) 2002-04-02
US5922766A (en) 1999-07-13
HK1028713A1 (en) 2001-03-02
EP0994657B1 (en) 2004-01-28
NO20000010L (no) 2000-03-01
PT994657E (pt) 2004-06-30
EP0994657A1 (en) 2000-04-26
ES2215304T3 (es) 2004-10-01

Similar Documents

Publication Publication Date Title
ATE258386T1 (de) Schmackhaftes elementares medizinisches nahrungsmittel
ATE147592T1 (de) Vitamine und mineralien enthaltende nahrungszusätze
ATE257331T1 (de) Dietetische baby nahrungsmittel mit konjugierten linoleinsäuren
FR2721481B1 (fr) Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel.
NO922183L (no) Fettsyreblandinger
DE69806820D1 (de) Kaloriereiche ernährungszusammensetzung
NO990940D0 (no) Ernµringssammensetning for fenylketonuripasienter
ATE167983T1 (de) Phospholipidhaltige fettmischung mit lcp- fettsäuren
ATE258792T1 (de) Diät mit hohem lipidgehalt
ATE354972T1 (de) Lipid mischungen und lebensmittel, enthaltend ölsäure und omega-6 fettsäuren, die die intramyozelluläre lipidkonzentration erhöhen
ATE248528T1 (de) Nahrungsmittel mit biotin und anderen b-vitaminen
NO951992D0 (no) Dietisk næringsmiddel med fettsyrer av middels lengde og anvendelse av dette
ATE84677T1 (de) Diaetoel.
WO1999037167A3 (en) Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby
ATE288208T1 (de) Diätetisches lebensmittel
DE60210245D1 (de) Diätetisches Milch- und Sojaersatzprodukt
MY136730A (en) Fish oil and garlic nutritive composition
TH50165S (th) - ภาชนะใส่อาหาร

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0994657

Country of ref document: EP